Related Experiment Video
Updated: Aug 30, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Dynamic regulation of P-TEFb by 7SK snRNP is integral to the DNA damage response to regulate chemotherapy sensitivity
Yin Fang1, Yan Wang1, Benjamin M Spector2
1Departments of Pediatrics and Obstetrics & Gynecology, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Center of Growth, Metabolism and Aging, College of Life Sciences, State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu 610041, China.
Abstract:
Testicular germ cell tumors and closely related embryonal stem cells are exquisitely sensitive to cisplatin, a feature thought to be linked to their pluripotent state and p53 status. It remains unclear whether and how cellular state is coordinated with p53 to confer cisplatin sensitivity. Here, we report that positive transcription elongation factor b (P-TEFb) determines cell fate upon DNA damage. We find that cisplatin rapidly activates P-TEFb by releasing it from inhibitory 7SK small nuclear ribonucleoprotein complex. P-TEFb directly phosphorylates pluripotency factor estrogen-related receptor beta (ESRRB), and induces its proteasomal degradation to enhance pro-survival glycolysis. On the other hand, P-TEFb is required for the transcription of a substantial portion of p53 target genes, triggering cell death during prolonged cisplatin treatment. These results reveal previously underappreciated roles of P-TEFb to coordinate the DNA damage response. We discuss the implications for using P-TEFb inhibitors to treat cancer and ameliorate cisplatin-induced ototoxicity.
Insights
Positive Transcription Elongation Factor b (P-TEFb) dictates cell fate after DNA damage, coordinating responses to cisplatin chemotherapy. P-TEFb activation promotes survival pathways initially, then triggers cell death, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cellular Biology
Background:
- Testicular germ cell tumors and embryonal stem cells show high sensitivity to cisplatin.
- The interplay between cellular state, p53, and cisplatin sensitivity is not fully understood.
Purpose of the Study:
- To elucidate the role of Positive Transcription Elongation Factor b (P-TEFb) in coordinating cellular responses to DNA damage.
- To investigate how P-TEFb influences cell fate and cisplatin sensitivity.
Main Methods:
- Investigated P-TEFb activation upon cisplatin treatment.
- Assessed P-TEFb's effect on estrogen-related receptor beta (ESRRB) phosphorylation and degradation.
- Analyzed P-TEFb's role in p53 target gene transcription.
Main Results:
- Cisplatin rapidly activates P-TEFb by dissociating it from the 7SK small nuclear ribonucleoprotein complex.
- P-TEFb phosphorylates and promotes proteasomal degradation of ESRRB, enhancing glycolysis for survival.
- P-TEFb is essential for transcribing p53 target genes, leading to cell death during prolonged cisplatin exposure.
Conclusions:
- P-TEFb plays a dual role in DNA damage response, initially promoting survival and later inducing cell death.
- P-TEFb acts as a key coordinator between cellular state and p53-mediated responses to DNA damage.
- Targeting P-TEFb may offer novel strategies for cancer treatment and mitigating cisplatin-induced ototoxicity.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Base Excision Repair
The first step of...
Long-patch Base Excision Repair
Abnormal Proliferation
Negative Regulator Molecules

